In what world does it make sense that one cannot communicate this good news to the members of the study section that is about to review your R01? Livelihoods are at stake!😖
Thrilled to report our paper by Acosta et al. "p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism" was accepted for publication at Nature Comms! @NatureComms@PennCBP
Thrilled to report our paper by Acosta et al. "p53 restoration in small cell lung cancer identifies a latent cyclophilin-dependent necrosis mechanism" was accepted for publication at Nature Comms! @NatureComms@PennCBP
From @FeldserLab: SETD2 inactivation leads to heightened mTORC1 signaling, oxidative metabolism and protein synthesis in KRAS-driven mouse models of lung adenocarcinoma, revealing more about how SETD2 deficiency drives early and widespread tumor growth
https://t.co/Y4w6KVwmxm
Congrats to Kim Manning for winning the poster award in the Cancer Biology category at the Annual Biomedical Research Conference!! So proud of Kim and all of her awesome achievements!!!
@IDEAL_Research@ABRCMS@CAMBUpenn#PennCancerResearch
The Feldser Lab is searching for a talented grad student or postdoc to elucidate the molecular underpinnings of a novel p53-mediated cell death program in small cell lung cancer that involves ER-directed autophagy prior to cell explosion! Contact David via email if interested.
Announcing the creation of Team "NextGen Cures" for the Breakthrough Challenge event benefitting Penn Medicine's Abramson Cancer Center
Check out our team page to join and donate!
https://t.co/hdcLk930bg
https://t.co/e98LvwaS87
#PennCancerResearch@PennCancer@CAMBUpenn